Tessera Therapeutics Revenue and Competitors

Claim your profile

Boston, MA USA

Location

#489

Growjo Ranking

Biotech

Industry

Estimated Revenue & Valuation

  • Tessera Therapeutics's estimated annual revenue is currently $45.4M per year.(i)
  • Tessera Therapeutics's estimated revenue per employee is $142,367
  • Tessera Therapeutics's total funding is $431.8M.
  • Tessera Therapeutics's current valuation is $1.7B. (April 2022)

Employee Data

  • Tessera Therapeutics has 319 Employees.(i)
  • Tessera Therapeutics grew their employee count by 50% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.2M1-99%N/AN/A
#2
$3.1M20233%N/AN/A
#3
$21.5M12518%$351MN/A
#4
$18M1165%$312.8MN/A
#5
$235M269-43%$340.9MN/A
#6
$2.2M3417%N/AN/A
#7
$6M40-9%$176.5MN/A
#8
$1.8M28367%N/AN/A
#9
$109.4M70614%N/AN/A
#10
$6.2M40233%N/AN/A

Our mission is to cure disease by writing the code of life

keywords:N/A

$431.8M

Total Funding

319

Number of Employees

$45.4M

Revenue (est)

50%

Employee Growth %

$1.7B

Valuation

N/A

Accelerator

Tessera Therapeutics News

2022-04-17 - Tessera Therapeutics Raises Over $300M in Series C Financing

Tessera Therapeutics, a Somerville, MA-based biotechnology company, raised over $300M in Series C funding.

2022-04-17 - Tessera Therapeutics stacks up more than $300M in series C funds ...

Tessera Therapeutics, founded and created by life sciences VC staple Flagship Pioneering, is building a war chest with a fresh $300 million...

2022-04-17 - Tessera Therapeutics Announces Over $300M Series C Financing ...

Tessera Therapeutics is pioneering GENE WRITING technology, which consists of multiple technology platforms designed to offer scientists and...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$108.3M3214%N/A
#2
$130.4M3232%N/A
#3
$47.3M32727%$520M
#4
$73.6M327N/AN/A
#5
$79.9M33225%$382M